Table IV.
Correlations of antibodies with histopathological data.
Antigen | Tumour size (pT) | LNI | Differentiation grade | ER/PR | Her-2/neu |
---|---|---|---|---|---|
TRα1/2 | ns | ns | ns | ns | ns |
TRα1 | cc=−0.357, P=0.001 | ns | ns | ns | ns |
TRα2 | cc=−0.329, P=0.003 | cc=−0.487, P=0.002 | cc=−0.542, P=0.009 | cc=0.248, P=0.028 | ns |
TRβ1/2 | ns | ns | ns | cc=−0.349, P=0.002 | ns |
TRβ1 | cc=−0.293, P=0.009 | ns | ns | cc=0.252, P=0.025 | ns |
TRβ2 | cc=−0.314, P=0.006 | ns | ns | ns | ns |
RXRα | ns | ns | cc=−0.248, P=0.029 | ns | ns |
PPARγ | ns | cc=0.318, P=0.005 | cc=0.225, P=0.047 | ns | ns |
VDR | cc=−0.278, P=0.016 | cc=0.411, P<0.01 | ns | ns | ns |
LNI, lymph node involvement; ER, oestrogen receptor; PR, progesterone receptor; TR, thyroid receptor; RXR, retinoid X receptor; PPAR, peroxisome proliferator-activated receptor; VDR, vitamin D receptor; cc, coefficient of correlation; ns, not statistically significant. Data presented as correlation coefficient and P-values.